Nicotinic acid induces apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines

Metabolism: Clinical and Experimental

Volumn 60, Issue 12, 2011, Pages 1790-1796

  Haas, Michael J ^a   Alamir, Abdul Razzak ^a   Sultan, Senan ^a   Chehade, Joe M ^a   Wong, Norman C N ^b   Mooradian, Arshag D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; MESSENGER RNA; NICOTINIC ACID;

ARTICLE; BASE PAIRING; CELL STRAIN CACO 2; CELL STRAIN HEPG2; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE; WESTERN BLOTTING;

APOLIPOPROTEIN A-I; BLOTTING, WESTERN; CACO-2 CELLS; GENE EXPRESSION; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; NIACIN; PLASMIDS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCES, NUCLEIC ACID; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSFECTION;

EID: 81155131769     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.05.005     Document Type: Article

References (28)

1. S.B. Hachem, and A.D. Mooradian Familial dyslipidaemias: an overview of genetics, pathophysiology and management Drugs 66 2006 1949 1969 (Pubitemid 44771933)
2. M.J. Haas, and A.D. Mooradian Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection Drugs 70 2010 805 821
3. J. Shepherd, C.J. Packard, J.R. Patsch, A.M. Gotto Jr, and O.D. Taunton Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism J Clin Invest 63 1979 858 867 (Pubitemid 9182535)
4. F.Y. Jin, V.S. Kamanna, and M.L. Kashyap Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by HepG2 cells. Implication for reverse cholesterol transport Arterioscler Thromb Vasc Biol 17 1997 2020 2028 (Pubitemid 28057103)
5. L.H. Zhang, V.S. Kamanna, M.C. Zhang, and M.L. Kashyap Niacin inhibits surface expression of ATP synthase beta chain in HepG2 cells: implications for raising HDL J Lipid Res 49 2008 1195 1201
6. P. Siripurkpong, and K. Na-Bangchang Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells J Nutr Biochem 20 2009 261 268
7. S. Lamon-Fava, M.R. Diffenderfer, P.H. Barrett, A. Buchsbaum, M. Nyaku, and K.V. Horvath Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and apo B-containing lipoproteins Arterioscler Thromb Vasc Biol 28 2008 1672 1678
8. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
9. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
10. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci U S A 76 1979 4350 4354 (Pubitemid 9256559)
11. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159 (Pubitemid 17064313)
12. C. Parolini, G. Chiesa, Y. Zhu, T. Forte, S. Caligari, and E. Gianazza Targeted replacement of mouse apolipoprotein A-I with human apo A-I or the mutant apo A-I Milano. Evidence of APOA-IM impaired hepatic secretion J Biol Chem 278 2003 4740 4746 (Pubitemid 36800975)
13. G. Carrano, G. Albertin, M. Forneris, and G.G. Nussdorfer Similar sequence-free amplification of human glyceraldehydes-3-phosphate dehydrogenase for real time RT-PCR applications Mol Cell Probes 19 2005 181 186 (Pubitemid 40432092)
14. S. Lefever, J. Vandesompele, F. Speleman, and F. Pattyn RTPrimerDB; the portal for real-time PCR primers and probes Nucleic Acids Res 37 Database issue 2009 D942 D945
15. M.J. Haas, M. Horani, A. Mreyoud, B. Plummer, N.C. Wong, and A.D. Mooradian Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta Biochim Biophys Acta 1623 2003 120 128 (Pubitemid 37315668)
16. A.H. Taylor, P. Wishart, D.E. Lawless, J. Raymond, and N.C. Wong Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter Biochemistry 35 1996 8281 8288 (Pubitemid 26234931)
17. C.M. Gorman, L.F. Moffat, and B.H. Howard Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells Mol Cell Biol 2 1982 1044 1051 (Pubitemid 13227227)
18. P. Herbomel, B. Bourachot, and M. Yaniv Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma Cell 39 1984 653 662 (Pubitemid 15198603)
19. R.L. Widom, J.A. Ladias, S. Kouidou, and S.K. Karathanasis Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells Mol Cell Biol 11 1991 677 687 (Pubitemid 21895415)
20. V.S. Kamanna, and M.L. Kashyap Mechanism of action of niacin Am J Cardiol 101 8A 2008 20B 26B
21. A. Gille, E.T. Bodor, K. Ahmed, and S. Offermanns Nicotinic acid: pharmacological effects and mechanisms of action Annu Rev Pharmacol Toxicol 48 2008 79 106 (Pubitemid 351738150)
22. M. Weiner Clinical pharmacology and pharmacokinetics of nicotinic acid Drug Metab Rev 9 1979 99 106 (Pubitemid 10199189)
23. J. Le Bloc'h, V. Leray, M. Chetiveaux, B. Freuchet, T. Magot, and M. Krempf Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs J Pharmacol Exp Ther 334 2010 583 589
24. L.H. Zhang, V.S. Kamanna, M.C. Zhang, and M.L. Kashyap Niacin inhibits surface expression of ATP synthase β chain in HepG2 cells: implications for raising HDL J Lipid Res 49 2008 1195 1201
25. S.H. Ganji, S. Qin, L. Zhang, V.S. Kamanna, and M.L. Kashyap Niacin inhibits vascular oxidative stress, redo-sensitive genes, and monocyte adhesion to human aortic endothelial cells Atherosclerosis 202 2009 68 75
26. L. Yvan-Charvet, J. Kling, T. Pagler, H. Li, B. Hubbard, and T. Fisher Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib Arterioscler Thromb Vasc Biol 30 2010 1430 1438
27. Z.H. Wu, and S.P. Zhao Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes Pharmacology 84 2009 282 287
28. S. Choi, H. Yoon, K.S. Oh, Y.T. Oh, Y.I. Kim, I. Kang, and J.H. Youn Widespread effects of nicotinic acid on gene expression in insulin-sensitive tissues: implications for unwanted effects of nicotinic acid treatment Metabolism 60 2011 134 144